Related Experiment Videos
[Diagnosis of treated and untreated chronic-aggressive hepatitis]
Insights
Long-term treatment with corticosteroids and azathioprine significantly improves the prognosis for patients with chronic active hepatitis (CAH). This approach led to a lower death rate compared to no or short-term therapy.
Area of Science:
- Hepatology
- Immunosuppressive Therapy
- Clinical Medicine
Background:
- Chronic active hepatitis (CAH) poses significant long-term health risks.
- Treatment strategies for CAH vary, impacting patient outcomes.
- Understanding the long-term effects of immunosuppressive therapy is crucial.
Purpose of the Study:
- To evaluate the long-term efficacy of corticosteroids and azathioprine in managing chronic active hepatitis.
- To compare patient prognosis under different treatment durations for CAH.
- To determine the impact of treatment intensity on mortality rates in CAH patients.
Main Methods:
- A cohort of 121 chronic active hepatitis patients from two hospitals was followed for over 5 years.
- One group received consistent corticosteroid and azathioprine treatment.
- The control group received no treatment unless severe deterioration occurred, with treatment kept brief.
Main Results:
- Long-term treatment demonstrated a superior prognosis compared to no or short-term treatment.
- The death rate per patient-year was lowest in the long-time therapy group (0.025).
- Mortality rates were higher in the no-therapy (0.079) and short-therapy (0.035) groups.
Conclusions:
- Sustained immunosuppressive therapy with corticosteroids and azathioprine is associated with improved survival in chronic active hepatitis.
- Early and consistent treatment appears more beneficial than delayed or intermittent approaches.
- The findings support aggressive, long-term management strategies for CAH.
Abstract:
A total of 121 patients with chronic active hepatitis (CAH) of two Zurich hospitals were controlled over a mean time of 5 years and 4 months. All patients of one hospital were consequently treated with corticosteroids and azathioprine, whereas those of the other hospital were not treated unless a severe deterioration occurred. In this case treatment was as short as possible. Results indicate that long - time treatment of CAH results in better prognosis than does no or short - time treatment. Death rate per observed patient - year was 0.079 in the no - therapy group, 0.035 in the short - therapy group and 0.025 in the long - time therapy group.